PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumab.

Publication Title

Oncoimmunology

Authors

• Gabriele Madonna
• Carmen Ballesteros-Merino, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA.Follow
• Zipei Feng, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA; Department of Cancer Biology, Oregon Health & Science University, Portland, OR, USA.Follow
• Carlo Bifulco, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA; Department of Pathology, Providence Portland Medical Center, Portland, OR, USA.Follow
• Mariaelena Capone
• Diana Giannarelli
• Domenico Mallardo
• Ester Simeone
• Antonio M Grimaldi
• Corrado Caracò
• Gerardo Botti
• Bernard A Fox, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA; Department of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR, USA.Follow
• Paolo A Ascierto

Document Type

Article

Publication Date

1-1-2018

Keywords

Immunotherapy; Ipilimumab; Melanoma; PD-L1; Tumor microenvironment; genomics

Area of Special Interest

Cancer

Specialty/Research Institute

Earle A. Chiles Research Institute

Specialty/Research Institute

Oncology